| Title | A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Assess the Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis |
|---|---|
| Disease/Condition | Skin Disorders,Genetic Disorders,Dermatology,Immune System Diseases |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Steven Cohen, MD |
| Contact Name | Jose Jaller |
| Contact Email | jjaller@montefiore.org |
| Protocol Number | 18-02-362-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Dermatology |
| Adult, Pediatric, Both | Adult |